Advanced Search: Newly Diagnosed

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_Coordination_Center@bjc.org.

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

201604115

A phase I/II dose-escalation and dose-expansion study of disulfiram/copper with concurrent radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

201512009

A Phase I and Pilot Study of the Effects of rhIL-7-hyFc (NT-17) on CD4 Counts in Patients with High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia after Concurrent Radiation and Temozolomide

201810185

Effect of rhIL-7-hyFc on increasing lymphocyte counts in patients with newly diagnosed non-severe lymphopenic gliomas following radiation and temozolomide

202103257

A phase IB study to use tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wildtype grade III-IV astrocytoma

201905095

GBM AGILE

202003072

A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized DNA Vaccine in Patients with Newly Diagnosed, Unmethylated Glioblastoma

202006111

A feasibility study to correlate cognitive changes of IDH-mutant and IDH-wildtype glioma patients after chemoradiotherapy with radiation dose to the resting state networks

201411046

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma (BN001)

202012017

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1